Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 23,618Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 14Merck Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Merck Canada Inc.

arrow
Coatings Trends
Not Confirmed

Merck Canada Inc.

Country
arrow
Coatings Trends
Not Confirmed

ERTUGLIFLOZIN

Brand Name : STEGLATRO

Patent Number : 2733795

Filing Date : 2009-08-17

Strength per Unit : 5 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-08-17

Date Granted : 2013-12-31

blank

02

Merck Canada Inc.

arrow
Coatings Trends
Not Confirmed

Merck Canada Inc.

Country
arrow
Coatings Trends
Not Confirmed

ERTUGLIFLOZIN

Brand Name : STEGLATRO

Patent Number : 2733795

Filing Date : 2009-08-17

Strength per Unit : 15 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-08-17

Date Granted : 2013-12-31

blank

03

arrow
Coatings Trends
Not Confirmed

Merck Canada Inc.

Country
arrow
Coatings Trends
Not Confirmed

ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE

Brand Name : STEGLUJAN

Patent Number : 2733795

Filing Date : 2009-08-17

Strength per Unit : 15 mg / 100mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-08-17

Date Granted : 2013-12-31

blank

04

arrow
Coatings Trends
Not Confirmed

Merck Canada Inc.

Country
arrow
Coatings Trends
Not Confirmed

ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE

Brand Name : STEGLUJAN

Patent Number : 2536251

Filing Date : 2004-08-27

Strength per Unit : 15 mg / 100mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-08-27

Date Granted : 2009-08-04

blank

05

arrow
Coatings Trends
Not Confirmed

Merck Canada Inc.

Country
arrow
Coatings Trends
Not Confirmed

ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE

Brand Name : STEGLUJAN

Patent Number : 2529400

Filing Date : 2004-06-18

Strength per Unit : 15 mg / 100mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-06-18

Date Granted : 2007-10-09

blank

06

arrow
Coatings Trends
Not Confirmed

Merck Canada Inc.

Country
arrow
Coatings Trends
Not Confirmed

ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE

Brand Name : STEGLUJAN

Patent Number : 2450740

Filing Date : 2002-07-05

Strength per Unit : 15 mg / 100mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-07-05

Date Granted : 2006-02-14

blank

07

arrow
Coatings Trends
Not Confirmed

Merck Canada Inc.

Country
arrow
Coatings Trends
Not Confirmed

ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE

Brand Name : STEGLUJAN

Patent Number : 2536251

Filing Date : 2004-08-27

Strength per Unit : 5 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-08-27

Date Granted : 2009-08-04

blank

08

arrow
Coatings Trends
Not Confirmed

Merck Canada Inc.

Country
arrow
Coatings Trends
Not Confirmed

ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE

Brand Name : STEGLUJAN

Patent Number : 2450740

Filing Date : 2002-07-05

Strength per Unit : 5 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-07-05

Date Granted : 2006-02-14

blank

09

arrow
Coatings Trends
Not Confirmed

Merck Canada Inc.

Country
arrow
Coatings Trends
Not Confirmed

ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE

Brand Name : STEGLUJAN

Patent Number : 2529400

Filing Date : 2004-06-18

Strength per Unit : 5 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-06-18

Date Granted : 2007-10-09

blank

10

arrow
Coatings Trends
Not Confirmed

Merck Canada Inc.

Country
arrow
Coatings Trends
Not Confirmed

ERTUGLIFLOZIN, SITAGLIPTIN PHOSPHATE

Brand Name : STEGLUJAN

Patent Number : 2733795

Filing Date : 2009-08-17

Strength per Unit : 5 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-08-17

Date Granted : 2013-12-31

blank